Skip to main content
×
×
Home

Continuity of supply of psychiatric medicines for newly received prisoners

  • Lamiece Hassan (a1) (a2), Jane Senior (a1), Dawn Edge (a3) and Jenny Shaw (a1) (a2)
Abstract
Aims and method

A retrospective case-note review was undertaken at five English prisons between June 2008 and March 2009 to estimate the proportion of psychiatric medicines (antidepressants, antipsychotics and hypnotics/anxiolytics) reported at prison reception that are discontinued on entry to prison.

Results

Of the 1006 records sampled, the review showed that 18% of prisoners had been prescribed psychiatric medication before being placed in custody. Altogether, 240 separate psychiatric medicines were recorded among prisoners at reception. Of these, 47% were not prescribed during the first week of custody. In only 11% of cases where medication was discontinued had psychiatric assessment been completed.

Clinical implications

Prison mental health policy states that psychiatric medication should not be withdrawn in custody without proper clinical assessment. Denial of medication in the absence of clinical assessment during early custody has the potential to create additional stress in individuals during a period of increased vulnerability and risk.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Continuity of supply of psychiatric medicines for newly received prisoners
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Continuity of supply of psychiatric medicines for newly received prisoners
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Continuity of supply of psychiatric medicines for newly received prisoners
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
Lamiece Hassan (lamiece.hassan@nhs.net)
Footnotes
Hide All

Declaration of interest

None.

Footnotes
References
Hide All
1 Bradley K. The Bradley Report: Lord Bradley's Review of People with Mental Health Problems or Learning Disabilities in the Criminal Justice System. Department of Health, 2009.
2 Department of Health. Improving Health, Supporting Justice: The National Delivery Plan of the Health and Criminal Justice Programme Board. Department of Health, 2009.
3 Bullmore E, Fletcher P, Jones PB. Why psychiatry can't afford to be neurophobic. Br J Psychiatry 2009; 194: 293–5.
4 Dolan KA, Shearer J, MacDonald M, Mattick RP, Hall W, Wodak AD. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend 2003; 72: 5965.
5 Department of Health. A Pharmacy Service for Prisoners. Department of Health, 2003.
6 Department of Health, HMPS. Changing the Outlook: A Strategy for Developing and Modernising Mental Health Services in Prison. Department of Health, 2001.
7 Haddad PM, Anderson IM. Recognising and managing antidepressant discontinuation symptoms. Adv Psychiatr Treat 2007; 13: 447–57.
8 Plugge E, Douglas N, Fitzpatrick R. Patients, prisoners or people. Women prisoners' experience of primary care in prison: a qualitative study. Br J Gen Pract 2008; 58: e18.
9 Bowen RA, Rogers A, Shaw J. Medication management and practices in prison for people with mental health problems: a qualitative study. Int J Ment Health Syst 2009; 3: 24.
10 Condon L, Hek G, Harris F, Powell J, Kemple T, Price S. Users' views of prison health services: a qualitative study. J Adv Nurs 2007; 58: 216–26.
11 Shaw J, Baker D, Hunt IM, Moloney A, Appleby L. Suicide by prisoners. National clinical survey. Br J Psychiatry 2004; 184: 263–7.
12 BMJ Group, Royal Pharmaceutical Society of Great Britain. British National Formulary 58. BMJ Group & Pharmaceutical Press, 2009.
13 National Institute for Health and Clinical Excellence. Depression: The Treatment and Management of Depression in Adults (Update). NICE, 2009.
14 National Institute for Health and Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care. NICE, 2009.
15 Moncrieff J. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Acta Psychiatr Scand 2006; 114: 313.
16 Lejoyeux M, Ades J. Antidepressant discontinuation: a review of the literature. J Clin Psychiatry 1997; 58 (suppl 7): 11–6.
17 Moncrieff J. Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem. Med Hypotheses 2006; 67: 517–23.
18 Fialip J, Aumaitre O, Eschalier A, Maradeix B, Dordain G, Lavarenne J. Benzodiazepine withdrawal seizures: analysis of 48 case reports. Clin Neuropharmacol 1987; 10: 538–44.
19 Mellor PA. The inside story on prison health care. BMJ 2003; 326: 59.
20 National Prescribing Centre. Medicines Reconciliation: A Guide to Implementation. National Prescribing Centre, 2008.
21 National Institute for Health and Clinical Excellence. PSG001 Technical Patient Safety Solutions for Medicines Reconciliation on Admission of Adults to Hospital. NICE, 2007.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 1758-3209
  • EISSN: 1758-3217
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 1 *
Loading metrics...

Abstract views

Total abstract views: 2 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 25th February 2018. This data will be updated every 24 hours.

Continuity of supply of psychiatric medicines for newly received prisoners

  • Lamiece Hassan (a1) (a2), Jane Senior (a1), Dawn Edge (a3) and Jenny Shaw (a1) (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *